Valeda Photobiomodulation Near Rockland County, NY
- Home
- General
Valeda Photobiomodulation
Patients in Rockland County exploring treatment options for dry age-related macular degeneration (AMD) can visit phRETINA in nearby Nanuet, NY. Led by Dr. Paul Hahn, MD, PhD, FASRS, phRETINA offers Valeda photobiomodulation therapy for eligible patients with dry age-related macular degeneration (AMD)
He also holds leadership roles on the Executive Committee of the American Society of Retina Specialists, the largest organization of retina specialists in the world, and is in line to become its President.
What Is Valeda Photobiomodulation?
Valeda photobiomodulation is a non-invasive, light-based treatment that uses specific wavelengths of light to support retinal cell function in eligible patients with dry AMD.
The Valeda Light Delivery System received FDA authorization in November 2024 for a defined group of patients with dry age-related macular degeneration.
It offers a treatment option for certain patients who meet the clinical eligibility criteria.
Meet Dr. Paul Hahn, Retina Specialist
Dr. Paul Hahn is a board-certified, fellowship-trained retina specialist with over 15 years of academic, clinical, and surgical experience. He trained at Harvard, the University of Pennsylvania, and Duke University Eye Center, where he completed a fellowship in vitreoretinal diseases and surgery.
He also served as an Assistant Professor at Duke and led more than 30 clinical trials in retinal disease.
His work combines specialized retinal care with research and surgical expertise. Dr. Hahn has published more than 100 peer-reviewed articles and book chapters.
At phRETINA, he brings this experience to the evaluation and treatment of retinal conditions, including dry AMD, with careful assessment and individualized recommendations.
Valeda Therapy for AMD
Valeda therapy uses carefully controlled red, yellow, and near-infrared light delivered through a specialized device during in-office sessions.
This process, known as photobiomodulation, is designed to support cellular activity in the retina and may help improve visual acuity in appropriately selected patients.
Valeda treatment for macular degeneration is not a cure, and it is not suitable for every patient. A comprehensive retinal examination and imaging help Dr. Hahn determine whether Valeda is an appropriate option based on the stage of dry AMD and the patient's retinal health.
Who May Be Eligible for Valeda Treatment?
Valeda for AMD is intended for certain patients with dry age-related macular degeneration who meet specific clinical criteria. Eligibility depends on factors such as visual acuity, retinal findings, and the presence or absence of particular disease features.
Patients with wet AMD or center-involving geographic atrophy may not meet the treatment criteria.
If you are considering Valeda photobiomodulation therapy near Rockland County, Dr. Hahn can evaluate your retina, review your imaging results, and discuss whether this treatment is suitable for you.
What Can I Expect During
Valeda Treatment?
Your visit begins with a comprehensive retinal evaluation, which may include a dilated examination and advanced retinal imaging. If you qualify for treatment, the Valeda device delivers controlled light to the eyes during a series of scheduled in-office sessions. The procedure is non-invasive and generally painless, without injections or surgery.
Dr. Hahn will explain the recommended treatment schedule, monitor your retinal health, and discuss what results you can reasonably expect. Individual responses vary, and ongoing follow-up remains important.
Frequently Asked Questions About Valeda photobiomodulation
Schedule Your Visit
If you are looking for a Valeda doctor near Rockland County, schedule an appointment with phRETINA in nearby Nanuet, NY, to discuss Valeda photobiomodulation and your treatment options.